Skip to main content
. 2022 Oct 10;36:103224. doi: 10.1016/j.nicl.2022.103224

Fig. 1.

Fig. 1

Study flowchart for the NeuroPharm dataset presenting the assignment to the response and remission groups based on the clinical assessment of HAMD-6 at week 8.